PharmaCorp Rx Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	56	63	4	12	-
Market Cap Growth	408.56%	1387.38%	-64.51%	-	-
Enterprise Value	47	38	2	9	-
Last Close Price	0.47	0.54	0.21	0.60	-
PS Ratio	4.01	10.93	-	-	-
PB Ratio	1.83	2.07	1.87	4.42	-
P/TBV Ratio	4.34	4.61	1.87	4.42	-
P/FCF Ratio	-	536.42	-	-	-
P/OCF Ratio	134.46	506.85	-	-	-
EV/Sales Ratio	3.40	6.54	-	-	-
EV/FCF Ratio	-27.30	321.02	-	-	-
Debt / Equity Ratio	0.03	0.03	-	-	-
Debt / FCF Ratio	-	8.07	-	-	-
Asset Turnover	0.47	0.31	-	-	-
Quick Ratio	4.77	7.79	48.54	166.01	37.20
Current Ratio	5.58	8.59	50.24	166.01	37.98
Return on Equity (ROE)	-1.46%	-6.40%	-18.85%	-28.02%	-
Return on Assets (ROA)	-1.80%	-5.29%	-14.29%	-18.85%	-
Return on Capital (ROIC)	-1.96%	-5.88%	-14.47%	-19.07%	-
Earnings Yield	-0.64%	-1.60%	-11.05%	-4.31%	-
FCF Yield	-3.11%	0.19%	-12.20%	-1.00%	-
Buyback Yield / Dilution	-20.45%	-303.02%	-1.39%	-23.69%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.